83 related articles for article (PubMed ID: 26187549)
1. Stat5a/b in Prostate Cancer Metastasis.
Gao AC; Zhu Y
Am J Pathol; 2015 Sep; 185(9):2351-3. PubMed ID: 26187549
[TBL] [Abstract][Full Text] [Related]
2. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.
Talati PG; Gu L; Ellsworth EM; Girondo MA; Trerotola M; Hoang DT; Leiby B; Dagvadorj A; McCue PA; Lallas CD; Trabulsi EJ; Gomella L; Aplin AE; Languino L; Fatatis A; Rui H; Nevalainen MT
Am J Pathol; 2015 Sep; 185(9):2505-22. PubMed ID: 26362718
[TBL] [Abstract][Full Text] [Related]
3. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
4. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
Tan SH; Nevalainen MT
Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
[TBL] [Abstract][Full Text] [Related]
7. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.
Koptyra M; Gupta S; Talati P; Nevalainen MT
Int J Biochem Cell Biol; 2011 Oct; 43(10):1417-21. PubMed ID: 21704724
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 expression is associated with JAK2V617F activity and regulates JAK2/STAT5 signaling.
Pagano F; Comoglio F; Grinfeld J; Li J; Godfrey A; Baxter J; Silber Y; Green AR
Leukemia; 2018 Aug; 32(8):1826-1830. PubMed ID: 29483713
[No Abstract] [Full Text] [Related]
10. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
Tan SH; Dagvadorj A; Shen F; Gu L; Liao Z; Abdulghani J; Zhang Y; Gelmann EP; Zellweger T; Culig Z; Visakorpi T; Bubendorf L; Kirken RA; Karras J; Nevalainen MT
Cancer Res; 2008 Jan; 68(1):236-48. PubMed ID: 18172316
[TBL] [Abstract][Full Text] [Related]
11. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.
Liao Z; Lutz J; Nevalainen MT
Int J Biochem Cell Biol; 2010 Feb; 42(2):186-92. PubMed ID: 19914392
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.
Gu L; Dagvadorj A; Lutz J; Leiby B; Bonuccelli G; Lisanti MP; Addya S; Fortina P; Dasgupta A; Hyslop T; Bubendorf L; Nevalainen MT
Am J Pathol; 2010 Apr; 176(4):1959-72. PubMed ID: 20167868
[TBL] [Abstract][Full Text] [Related]
14. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.
Røe K; Bratland Å; Vlatkovic L; Ragnum HB; Saelen MG; Olsen DR; Marignol L; Ree AH
PLoS One; 2013; 8(5):e63723. PubMed ID: 23675504
[TBL] [Abstract][Full Text] [Related]
16. Robust gene network analysis reveals alteration of the STAT5a network as a hallmark of prostate cancer.
Reddy A; Huang CC; Liu H; Delisi C; Nevalainen MT; Szalma S; Bhanot G
Genome Inform; 2010; 24():139-53. PubMed ID: 22081596
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
18. Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis.
Bougen NM; Amiry N; Yuan Y; Kong XJ; Pandey V; Vidal LJ; Perry JK; Zhu T; Lobie PE
Cancer Lett; 2013 May; 332(1):19-29. PubMed ID: 23266572
[TBL] [Abstract][Full Text] [Related]
19. Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin.
Balligand T; Achouri Y; Pecquet C; Chachoua I; Nivarthi H; Marty C; Vainchenker W; Plo I; Kralovics R; Constantinescu SN
Leukemia; 2016 Aug; 30(8):1775-8. PubMed ID: 26987905
[No Abstract] [Full Text] [Related]
20. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]